1. Home
  2. AXIL vs NSPR Comparison

AXIL vs NSPR Comparison

Compare AXIL & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

HOLD

Current Price

$6.24

Market Cap

39.5M

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.85

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXIL
NSPR
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
39.4M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
AXIL
NSPR
Price
$6.24
$0.85
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
35.0K
87.8K
Earning Date
04-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
230.00
N/A
EPS
0.33
N/A
Revenue
$30,847,570.00
$2,310,000.00
Revenue This Year
N/A
$57.98
Revenue Next Year
N/A
$95.41
P/E Ratio
$19.79
N/A
Revenue Growth
17.48
N/A
52 Week Low
$4.28
$0.63
52 Week High
$9.86
$2.57

Technical Indicators

Market Signals
Indicator
AXIL
NSPR
Relative Strength Index (RSI) 55.64 50.26
Support Level $5.79 $0.66
Resistance Level $7.38 $1.00
Average True Range (ATR) 0.53 0.08
MACD 0.06 -0.01
Stochastic Oscillator 43.53 15.53

Price Performance

Historical Comparison
AXIL
NSPR

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: